|
MRPL32 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.531800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.217850E-02 |
| Normal-vs-Stage2 |
2.598400E-01 |
| Normal-vs-Stage3 |
4.421100E-03 |
| Normal-vs-Stage4 |
5.012000E-01 |
| Stage1-vs-Stage2 |
4.934000E-01 |
| Stage1-vs-Stage3 |
4.27690000004421E-06 |
| Stage1-vs-Stage4 |
9.998200E-01 |
| Stage2-vs-Stage3 |
9.362100E-02 |
| Stage2-vs-Stage4 |
5.595000E-01 |
| Stage3-vs-Stage4 |
1.387790E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.488190E-01 |
| Normal-vs-AfricanAmerican |
1.144610E-01 |
| Normal-vs-Asian |
7.057800E-01 |
| Caucasian-vs-AfricanAmerican |
5.864200E-01 |
| Caucasian-vs-Asian |
9.658000E-01 |
| AfricanAmerican-vs-Asian |
8.780200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.028400E-02 |
| Normal-vs-Female |
8.950000E-01 |
| Male-vs-Female |
3.919700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.819200E-01 |
| Normal-vs-Extreme_Weight |
4.438300E-02 |
| Normal-vs-Obese |
5.685000E-01 |
| Normal-vs-Extreme_Obese |
1.153390E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.792390E-01 |
| Normal_Weight-vs-Obese |
8.791200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.193200E-01 |
| Extreme_Weight-vs-Obese |
1.701370E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.882600E-01 |
| Obese-vs-Extreme_Obese |
3.017600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.057600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.040400E-02 |
| Normal-vs-Age(61-80Yrs) |
2.405000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.012000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.110800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.778000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.832600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.724000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.440800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.854000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.71785999999452E-05 |
| Normal-VS-Type2 PRCC |
1.118610E-01 |
| Normal-VS-KIRP CIMP |
4.160700E-04 |
| Normal-VS-Unclassified PRCC |
6.648400E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.07750000000184E-06 |
| Type1 PRCC-VS-KIRP CIMP |
2.09749999999786E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
7.91079999951094E-07 |
| Type2 PRCC-VS-KIRP CIMP |
9.134300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.231600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.776960E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.420600E-01 |
| Normal-vs-N1 |
2.200500E-02 |
| Normal-vs-N2 |
2.287400E-01 |
| N0-vs-N1 |
1.057600E-01 |
| N0-vs-N2 |
1.766160E-01 |
| N1-vs-N2 |
2.656200E-01 |
|
|
